Results 21 to 30 of about 1,499,548 (192)

list of reviewer [PDF]

open access: yes, 2019
list of ...
list of reviewers, list of reviewers
core   +1 more source

Frontmatter (Titlepage, Table of Contents, Author List, PC List, Reviewer List)

open access: yes, 2010
Front matter including table of contents, author list, PC list, and reviewer ...
Lynch, Christopher
core   +1 more source

List of reviewers [PDF]

open access: yes, 2020
List of ...
Sordé Martí, Teresa
core  

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad   +9 more
wiley   +1 more source

“We Cannot Talk as a Family”: Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Young adult childhood cancer survivors (YA‐CCS) have an increased risk of treatment‐related health complications throughout their lives. Lifelong survivorship care is recommended, yet many YA‐CCS experience disruptions in care during pediatric‐to‐adult transitions and do not receive recommended survivorship care.
Kevin Shanchen Pu   +8 more
wiley   +1 more source

REVIEWER JPBI VOLUME 1 NOMOR 1

open access: yes, 2015
REVIEWER JPBI VOLUME 1 NOMOR 1     Naskah/artikel dalam penerbitan Volume 1 Nomor 1 ini telah direview oleh mitra bestari, sebagai berikut:   Dr. Akhmad Sukri, M.Pd. (IKIP Mataram) Dr. Marheny Lukitasari, M.Pd. (IKIP PGRI Madiun) Dra.
REVIEWER JPBI
core   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Towards a history of concept list compilation in historical linguistics [PDF]

open access: yes, 2018
Blog post, published with the blog "History and Philosophy of the Language Sciences". Here shared in form of a paper draft. Please cite as: List, Johann-Mattis. 2018. Towards a history of concept list compilation in historical linguistics.
Johann-Mattis List, List, J.
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy